Heart failure & cardiomyopathiesCohort study

Surgical myectomy for hypertrophic cardiomyopathy: procedural volume and outcomes

Eur Heart JPublished

  • Retrospective cohort study
  • multicentre
  • registry-based (Netherlands Heart Registration)
  • 12 Dutch hospitals

Authors' conclusion

Surgical myectomy with or without concomitant procedures effectively relieved LVOT obstruction in 93% of patients in this multicentre cohort. Female sex, ≥ 2 concomitant procedures, and low-volume hospitals were associated with higher 30-day complication rates.

Study context

Population
Hypertrophic obstructive cardiomyopathy (HOCM) patients undergoing surgical myectomy, 12 Dutch hospitals, 2012–2020
Participants
335 patients
Exposure
Low-volume vs higher-volume hospitals (and other factors) for 30-day complications after surgical myectomy
Outcome
30-day clinical outcomes and factors associated with increased 30-day complication rates
Follow-up
30 days

Main finding

30-day complications

Odds ratio

3.23

95% CI 1.43–8.09

P = 0.007

Low-volume vs higher-volume hospitals (and other factors) for 30-day complications after surgical myectomy
OR 3.23 (95% CI 1.43–8.09); P = 0.007

As reported in the abstract

30-day mortality
5%
30-day ventricular septal defect
2%
30-day stroke
3%
30-day surgical reoperation
2%

Observational data: associations, not effects.

Further findings

Haemodynamic and valvular changes after myectomy · postoperatively

Mean resting left ventricular outflow tract (LVOT) gradient, before → after
61 ± 30 mmHg to 13 ± 12 mmHg
Systolic anterior motion, before → after
80% to 8%
Mitral regurgitation grade 3 or 4, before → after
31% to 6%

Procedure type

Isolated myectomy
22%
Myectomy + one concomitant procedure
54%
Myectomy + ≥2 concomitant procedures
24%

Original publication

Surgical myectomy for hypertrophic cardiomyopathy: procedural volume and outcomes. Eur Heart J. Published 29 August 2025. doi:10.1093/eurheartj/ehaf560

Summarised from the published abstract; every number is checked against it